197 related articles for article (PubMed ID: 10829263)
1. Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations.
Bush LM; Johnson CC
Infect Dis Clin North Am; 2000 Jun; 14(2):409-33, ix. PubMed ID: 10829263
[TBL] [Abstract][Full Text] [Related]
2. Newer penicillins and beta-lactamase inhibitors.
Bush LM; Calmon J; Johnson CC
Infect Dis Clin North Am; 1995 Sep; 9(3):653-86. PubMed ID: 7490438
[TBL] [Abstract][Full Text] [Related]
3. Penicillins and beta-lactamase inhibitor combinations.
Mealey KL
J Am Vet Med Assoc; 2001 Jun; 218(12):1893-6. PubMed ID: 11417732
[TBL] [Abstract][Full Text] [Related]
4. Penicillins. A current review of their clinical pharmacology and therapeutic use.
Nathwani D; Wood MJ
Drugs; 1993 Jun; 45(6):866-894. PubMed ID: 7691496
[TBL] [Abstract][Full Text] [Related]
5. [Penicillins and beta-lactamase inhibitors].
Gac Med Mex; 1992; 128(2):127-30. PubMed ID: 1302208
[No Abstract] [Full Text] [Related]
6. Beta-lactam antibiotic and beta-lactamase inhibitor combinations.
Lee NL; Yuen KY; Kumana CR
JAMA; 2001 Jan 24-31; 285(4):386-8. PubMed ID: 11242403
[No Abstract] [Full Text] [Related]
7. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
[TBL] [Abstract][Full Text] [Related]
8. Novel beta-lactam antibiotics and inhibitor combinations.
Bassetti M; Righi E; Viscoli C
Expert Opin Investig Drugs; 2008 Mar; 17(3):285-96. PubMed ID: 18321228
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
10. What the Clinical Microbiologist Should Know About Pharmacokinetics/Pharmacodynamics in the Era of Emerging Multidrug Resistance: Focusing on β-Lactam/β-Lactamase Inhibitor Combinations.
Abodakpi H; Wanger A; Tam VH
Clin Lab Med; 2019 Sep; 39(3):473-485. PubMed ID: 31383269
[TBL] [Abstract][Full Text] [Related]
11. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
Sandanayaka VP; Prashad AS
Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
Lee N; Yuen KY; Kumana CR
Drugs; 2003; 63(14):1511-24. PubMed ID: 12834367
[TBL] [Abstract][Full Text] [Related]
13. Use of new beta-lactam antibiotics in intraabdominal surgery.
Kager L; Nord CE
Scand J Infect Dis Suppl; 1984; 42():143-50. PubMed ID: 6335598
[TBL] [Abstract][Full Text] [Related]
14. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
Rotschafer JC; Ostergaard BE
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
[TBL] [Abstract][Full Text] [Related]
15. Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics.
Tejedor-Junco MT; González-Martín M; Lupiola P; González-Lama Z
Folia Microbiol (Praha); 1998; 43(6):683-6. PubMed ID: 10069013
[TBL] [Abstract][Full Text] [Related]
16. [Beta-lactamase inhibitors].
Gialdroni Grassi G
G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
[No Abstract] [Full Text] [Related]
17. Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
Dudley MN
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S23-8. PubMed ID: 7606586
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
Okereke C; Dudley MN
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():43-9. PubMed ID: 9688450
[TBL] [Abstract][Full Text] [Related]
19. [Beta-lactamase inhibitors].
Launay O; Joly-Guillou ML; Decré D; Crémieux AC
Presse Med; 1997 Mar; 26(10):485-92. PubMed ID: 9137377
[TBL] [Abstract][Full Text] [Related]
20. [A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Nakagawa Y; Shimazu K; Ebihara M; Aman K
Kekkaku; 1999 May; 74(5):447-52. PubMed ID: 10386034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
